TRUGIN
DEAD

Serial Number

79406682

Owner

Zhejiang Huisong Pharmaceuticals Co., Ltd.

Filing Date

Apr 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TRUGIN Trademark

Serial Number: 79406682

TRUGIN is a trademark filed by Zhejiang Huisong Pharmaceuticals Co., Ltd. on April 22, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 30 (Staple Foods). The application is currently no longer active.

Owner Contact Info

Zhejiang Huisong Pharmaceuticals Co., Ltd. (2 trademarks)

No. 39, No. 25 Street,

Entity Type: 03

Trademark Details

Filing Date

April 22, 2024

Registration Date

Not Registered

Goods & Services

Drugs for medical purposes; disinfectants for hygiene purposes; solutions for contact lenses; dietetic foods adapted for medical purposes; air purifying preparations; medicines for veterinary purposes; preparations for destroying pests; disinfectant wipes; chinese medicinal preparations packed in a bag; dental abrasives.

Coffee-based beverages; tea-based beverages; natural sweeteners; sweets; royal jelly; oat flakes; cereal preparations; noodles; spices; essences for foodstuffs, except etheric essences and essential oils.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 2, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 16, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 16, 2026 OPNR
NEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2025 NREP
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 16, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 24, 2025 ABN2
REFUSAL PROCESSED BY IB
Dec 29, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 9, 2024 RFCS
REFUSAL PROCESSED BY MPU
Dec 9, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 23, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 22, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 18, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 18, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 17, 2024 REPR